Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $620.00.

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Resmed (RMD – Research Report) today and set a price target of $240.00. The ...

Paul Matteis, Stifel head of biotech research, joins 'The Exchange' to discuss the biotech trade under a new FDA amid the top vaccine official resigning. Voter Outrage in California Sparks ...

According to market observers, unlisted shares of Shri Ahimsa Naturals Ltd are currently trading at Rs 135 apiece, which is a 13.45 per cent premium (GMP) over the issue price of Rs 119. Its listing ...

Roper Technologies (NASDAQ:ROP) late Wednesday was rated Buy in new research coverage by analysts at financial-services firm Stifel. They cited the company's strong free cash flow, disciplined ...

Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me pepper her with questions for 40 minutes or so with Priya Singhal, Head of Development at ...